Paurush Babbar
Urology · Cincinnati, OHNPI 1770826695
Payments from drug & device makers
Across 468 payments — averaging $299.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$137K
- Astellas Pharma US Inc$372
- Endo USA, Inc.$353
- Sumitomo Pharma America, Inc.$228
- Bayer$214
- Endo Pharmaceuticals Inc.$208
- plus $2K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 299 | $136,693 |
| Astellas Pharma US Inc | 20 | $372 |
| Endo USA, Inc. | 13 | $353 |
| Sumitomo Pharma America, Inc. | 10 | $228 |
| Bayer | 12 | $214 |
| Endo Pharmaceuticals Inc. | 12 | $208 |
| Dendreon Pharmaceuticals LLC | 6 | $155 |
| Urogen Pharma, Inc. | 6 | $147 |
| Antares Pharma, Inc. | 7 | $135 |
| Axonics, Inc. | 8 | $132 |
| Accord Healthcare, Inc. | 7 | $119 |
| Merck | 4 | $109 |
| Immunitybio, Inc. | 3 | $107 |
| Progenics Pharmaceuticals, Inc. | 4 | $91 |
| Urovant Sciences Inc | 5 | $90 |
| Tolmar Pharmaceuticals, Inc. | 5 | $83 |
| Hollister Incorporated | 3 | $79 |
| Laborie Medical Technologies Corp. | 2 | $78 |
| Acerus Pharmaceuticals Corporation | 6 | $77 |
| Clarus Therapeutics Inc. | 7 | $75 |
| Johnson & Johnson | 4 | $71 |
| AbbVie(2 entities) | 3 | $68 |
| Tolmar, Inc. | 3 | $66 |
| Novartis | 2 | $57 |
| Teleflex LLC | 3 | $53 |
| Convatec Inc. | 1 | $48 |
| Pfizer | 3 | $43 |
| BD | 1 | $29 |
| Procept Biorobotics Corporation | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Myovant Sciences Inc. | 1 | $20 |
| Olympus America Inc. | 1 | $19 |
| Coloplast | 1 | $18 |
| Neotract Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Foundation Medicine, Inc. | 1 | $16 |
| Rigicon,inc. | 1 | $13 |
How this compares
$140,146 in reported general payments places this provider in the 90th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Cincinnati
- Marc PliskinCincinnati$20.8M
- Martin FritzhandCincinnati$4.6M
- Kamal PoharCincinnati$3.4M
- Abhinav SidanaCincinnati$334K
- Alberto MartiniCincinnati$145K
- Nilesh PatilCincinnati$80K
- Stephen BennettCincinnati$38K
- Lawrence GervasiMiddleburg Heights$4.7M
- Eric SingerColumbus$2.1M
- Benjamin MartinGahanna$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.